Geron (GERN) Interest Coverage Ratio Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn |
| 10 | Geron | 846,759.37 | 846,759.37 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.88% |
| Dec 31, 2025 | 35.29% |
| Sep 30, 2025 | 78.30% |
| Mar 31, 2025 | 64.92% |
| Dec 31, 2024 | -14.88% |
| Sep 30, 2024 | 54.40% |
| Jun 30, 2024 | 47.17% |
| Mar 31, 2024 | 51.79% |
| Dec 31, 2023 | 45.34% |
| Sep 30, 2023 | 28.03% |
| Jun 30, 2023 | 26.72% |
| Mar 31, 2023 | 44.97% |
| Dec 31, 2022 | 45.43% |
| Sep 30, 2022 | 44.09% |
| Jun 30, 2022 | 44.52% |
| Mar 31, 2022 | 44.15% |
| Dec 31, 2021 | 41.52% |
| Sep 30, 2021 | 33.36% |
| Jun 30, 2021 | 40.18% |
| Mar 31, 2021 | 38.41% |
| Dec 31, 2020 | 41.02% |
| Sep 30, 2020 | -36.37% |
| Mar 31, 2020 | 0.54% |
| Dec 31, 2019 | 49.14% |
| Sep 30, 2019 | -0.85% |
| Jun 30, 2019 | -6.14% |
| Mar 31, 2019 | -2.84% |
| Dec 31, 2018 | 9.11% |
| Sep 30, 2018 | 30.34% |
| Jun 30, 2018 | 28.14% |
| Mar 31, 2018 | 9.10% |
| Dec 31, 2017 | 15.88% |
| Sep 30, 2017 | -34.24% |
| Jun 30, 2017 | 18.29% |
| Mar 31, 2017 | 15.38% |
| Dec 31, 2016 | 4.98% |
| Sep 30, 2016 | -1.09% |
| Jun 30, 2016 | 7.45% |
| Mar 31, 2016 | 10.15% |
| Dec 31, 2015 | 6.61% |
| Sep 30, 2015 | 28.54% |
| Jun 30, 2015 | 8.59% |